Effects of Omega 3 in Hemodialysis Patients

This study has been completed.

First Received: February 3, 2007 No Changes Posted

Sponsored by:	Laboratoire Régional de Nutrition Humaine
Information provided by:	Laboratoire Régional de Nutrition Humaine
ClinicalTrials.gov Identifier:	NCT00431899

Purpose

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Condition	Intervention
Hemodialysis End Stage Renal Disease	Behavioral: fish oil supplementation

MedlinePlus related topics: Dialysis Dietary Supplements Kidney Failure

Drug Information available for: Fish oil

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Screening, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

Further study details as provided by Laboratoire Régional de Nutrition Humaine:

Primary Outcome Measures:

plasma glucose utilization
glucose-induced thermogenesis

Estimated Enrollment:	8
Study Start Date:	May 2003
Estimated Study Completion Date:	November 2003

Eligibility

Ages Eligible for Study:	18 Years to 75 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria:

- Age < 18 y ou > 75 y
Hemodialysis < 6 months
Diabetes, obesity
allergy to fish
Asthma
glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
erythropoïetin < 3 months
Cancer
Hemoglobin < 11 g/l
disease < 1 month
pregnancy
respiratory insufficiency
intensive sport practice
refusal

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00431899

Locations

France, 29
Laboratoire Régional de Nutrition Humaine
Brest, 29, France, F-29200

Sponsors and Collaborators

Laboratoire Régional de Nutrition Humaine

Investigators

Principal Investigator:

Jacques Delarue, MD,PhD

CHU Cavale Blanche F-29200 Brest

More Information

No publications provided

Study ID Numbers:	HDW3
Study First Received:	February 3, 2007
Last Updated:	February 3, 2007
ClinicalTrials.gov Identifier:	NCT00431899 History of Changes
Health Authority:	France: Ministry of Health

Keywords provided by Laboratoire Régional de Nutrition Humaine:

nutrition
omega 3 fatty acids
insulin resistance

Study placed in the following topic categories:

Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic
Kidney Failure, Chronic

Insulin Resistance
Kidney Diseases
Insulin
Kidney Failure

Additional relevant MeSH terms:

Renal Insufficiency
Urologic Diseases
Renal Insufficiency, Chronic

Kidney Failure, Chronic
Kidney Diseases
Kidney Failure

ClinicalTrials.gov processed this record on May 07, 2009